The top three players in the global Foot and Mouth Disease (FMD) such as Merial, MSD Animal Health (Merck), and Bayer AG account for 74.6% of the overall market. However, the global FMD market is highly fragmented due to the presence of many local players, reports Transparency Market Research (TMR) in a new study. Some of the local players are Agrovet, Brilliant Bio Pharma Ltd., Centro Diagnóstico Veterinario, Intervac (PVT) Ltd., Inova Biotecnologia Saúde Animal Ltda., Razi Vaccine & Serum Research Institute and Indian Immunologicals Limited.
“The manufacturers are competing not only with private players, but also governments of many countries who have set up their own FMD vaccines manufacturing units,” says the author of the report.
Growing Consumption of Meat in European Countries Boosts the Demand for FMD Vaccines
India, China, and Hong Kong are the top three countries of Asia involved in the export of beef and pork. Denmark, France, and Spain import most of their meat products from Asia. Thus, augmenting export of meat products increases the requirement of healthy livestock, thereby fueling the demand for FMD vaccines.
Countries in Asia and Africa encounter FMD outbreaks at an alarming rate. The governments of these countries are, thus, taking certain initiatives to control FMD outbreaks. Hence, favorable government initiatives are likely to accentuate the demand of FMD vaccines. A latest trend observed in the FMD vaccines market is the development of DNA vaccines. These vaccines provide better results and have a longer lasting effect than the conventional vaccines. Therefore, manufacturers are financing these vaccines in order to generate more revenue.
Government Intervention in Distribution Reduces the Cost of Vaccine
Governments play a vital role in the distribution of FMD vaccines. They purchase vaccines directly from manufacturers in bulk and supply it to various farms, vet clinics, and animal husbandries at a reduced rate. For instance, Government of India buys FMD vaccines from manufacturers in bulk during outbreaks and supplies it in different regions of the country.
There are seven different types of serotypes that can cause FMD. The FMD vaccines presently available are antigen specific and are ineffective on any other serotypes. As a result, increased outbreak of a particular type can challenge the growth of the market of remaining serotypes.
Increasing use of Conventional Vaccines in FMD-endemic Countries Benefits Growth of FMD Vaccines Market
The global foot and mouth disease vaccines market was valued at USD 513.6 million in 2013 and is anticipated to reach US$954.5 mn in 2020. By type, the market is segmented into conventional vaccines and emergency vaccines. “Conventional vaccines are more prevalent than emergency vaccines due to their augmented use in FMD-endemic countries,” says TMR analyst. In 2015, the valuation of conventional vaccines was US$414.6 mn and is expected to rise at US$313.4 mn in 2020. Conventional vaccines are further segmented into aluminum hydroxide/saponin-based vaccines and oil based vaccines.
By application, the cattle segment is the leading as well as the fastest growing segment by revenue in the global FMD vaccine market. Due to the presence of a large number of cattle in the FMD-endemic countries, the segment is expected to retain the leadership till 2020.
By geography, Asia Pacific held the largest market share by revenue and is anticipated to maintain the leadership by the end of 2020.
The information presented in this review is based on a Transparency Market Research report, titled, ‘Foot and Mouth Disease Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.’
The global foot and mouth disease vaccines market is segmented as follows:
Global Foot and Mouth Disease Vaccines Market, by Types
- Conventional Vaccines
- Aluminum Hydroxide/Saponin
- Oil Based
- Emergency Vaccines
Global Foot and Mouth Disease Vaccines Market, by Applications
- Sheep and Goats
Global Foot and Mouth Disease Vaccines Market, by Geography
- North America
- South Korea
- Rest of APAC
- Rest of the World
- Latin America
- South Africa
- Rest of Africa
- Rest of RoW
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453